[go: up one dir, main page]

AU2001229677A1 - Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses - Google Patents

Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses

Info

Publication number
AU2001229677A1
AU2001229677A1 AU2001229677A AU2967701A AU2001229677A1 AU 2001229677 A1 AU2001229677 A1 AU 2001229677A1 AU 2001229677 A AU2001229677 A AU 2001229677A AU 2967701 A AU2967701 A AU 2967701A AU 2001229677 A1 AU2001229677 A1 AU 2001229677A1
Authority
AU
Australia
Prior art keywords
live
immunodeficiency viruses
viral vaccines
recombinant rhabdoviruses
rhabdoviruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229677A
Inventor
Matthias J. Schnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of AU2001229677A1 publication Critical patent/AU2001229677A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20041Use of virus, viral particle or viral elements as a vector
    • C12N2760/20043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001229677A 2000-01-28 2001-01-22 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses Abandoned AU2001229677A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49426200A 2000-01-28 2000-01-28
US09494262 2000-01-28
PCT/US2001/001989 WO2001055330A2 (en) 2000-01-28 2001-01-22 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses

Publications (1)

Publication Number Publication Date
AU2001229677A1 true AU2001229677A1 (en) 2001-08-07

Family

ID=23963758

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229677A Abandoned AU2001229677A1 (en) 2000-01-28 2001-01-22 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses

Country Status (6)

Country Link
EP (1) EP1255849A2 (en)
JP (1) JP2003535577A (en)
CN (1) CN1416471A (en)
AU (1) AU2001229677A1 (en)
CA (1) CA2396709A1 (en)
WO (1) WO2001055330A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322119C (en) * 2002-11-14 2007-06-20 中国科学院水生生物研究所 Mandarin fish rhabdo virus toxic strain, its preparation method and application
BRPI0411099A (en) 2003-06-05 2006-07-18 Wyeth Corp immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus proteins antigens
CN105441483B (en) * 2005-10-14 2019-05-10 美国政府健康及人类服务部,疾病控制和预防中心 Rabies virus compositions and methods
CN101384278A (en) * 2005-12-14 2009-03-11 乔治亚大学研究基金公司 Rabies vaccine
RU2660566C2 (en) 2012-10-01 2018-07-06 Томас Джефферсон Юниверсити Immunization with a rabies virus vector expressing foreign protein antigen
CN106802348A (en) * 2016-12-30 2017-06-06 广东华南联合疫苗开发院有限公司 Sf Rhabdovirus N proteins Double-antibody sandwich enzymelinked immunosorbent detection kit and method
CN115960922A (en) * 2021-10-09 2023-04-14 吴可行 Design and application of self-replicating RNA molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001634A (en) * 1989-08-28 1999-12-14 Palese; Peter Recombinant negative strand RNA viruses
WO1996010400A1 (en) * 1994-09-30 1996-04-11 The Uab Research Foundation Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish

Also Published As

Publication number Publication date
JP2003535577A (en) 2003-12-02
WO2001055330A3 (en) 2002-03-28
EP1255849A2 (en) 2002-11-13
WO2001055330A2 (en) 2001-08-02
CN1416471A (en) 2003-05-07
CA2396709A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
PL362705A1 (en) Split enveloped virus preparation for intranasal delivery
GB0021281D0 (en) Software virus protection
AU2001240109A1 (en) Dna vaccines against poxviruses
IL150961A0 (en) Human immunodeficiency virus vaccine
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
IL153879A0 (en) Modified virus
AU2001238401A1 (en) Cold-adapted equine influenza viruses
AU2003301850A1 (en) Hiv vaccine
AU2001229677A1 (en) Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
AU2292600A (en) Varicella-zoster virus vaccines
AU2001278337A1 (en) Respiratory syncytial virus vaccine
GB0001475D0 (en) Virus strains
AU2001278323A1 (en) Modified sialic acid vaccines
GB0001476D0 (en) Herpes virus strains
AUPR160400A0 (en) Plant virus promoter
AU2002239462A1 (en) Compositions for protection against bovine viral diseases
AU2002221760A1 (en) Vaccine for treating allergy
AU4957800A (en) Vaccine against isa virus
AU2002236065A1 (en) Papillomavirus vaccines
AU2002314274A1 (en) Vaccination against the feline immunodeficiency virus
AU2002350181A1 (en) Compositions and methods for viral delivery
ZA200201446B (en) Babesia canis vaccine.
GB0111442D0 (en) Method for preparing recombinant virus
AU2001266534A1 (en) Papillomavirus vaccine
AU2001251761A1 (en) Equine protozoal myeloencephalitis vaccine